Document Detail


Prevention of left ventricular mural thrombus.
MedLine Citation:
PMID:  2750674     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute myocardial infarction is associated with a high incidence of left ventricular mural thrombosis, which causes most of the systemic emboli. A double-blind trial was undertaken in patients with anterior transmural myocardial infarction to evaluate the ability of a high-dose heparin regimen to prevent left ventricular mural thrombosis. The high dose consisted of 12,500 U of calcium heparin subcutaneously every 12 hours for 10 days, which was compared with a low dose consisting of 5,000 U every 12 hours. The formation of left ventricular mural thrombosis was assessed by means of 2-dimensional echocardiography on day 10 after infarction. The high-dose group had a significantly lower incidence of left ventricular mural thrombosis than did the low-dose group. This was achieved without increasing the incidence of bleeding. The benefits of high-dose heparin were associated with maintaining plasma heparin concentrations at 0.2 U/ml and activated partial thromboplastin time between 50 and 60 seconds.
Authors:
A G Turpie
Related Documents :
11687144 - Ticlopidine versus oral anticoagulation for coronary stenting.
9291244 - Design and methodology of the pursuit trial: evaluating eptifibatide for acute ischemic...
17892994 - Impact of bivalirudin on outcomes after percutaneous coronary revascularization with dr...
21901644 - Assessment of coronary flow reserve in the coronary sinus by cine 3t-magnetic resonance...
17584694 - Activation pattern of the avian left ventricle during ventricular pacing.
10746814 - Effects of carvedilol on left ventricular regional wall motion in patients with heart f...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  64     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1989 Jul 
Date Detail:
Created Date:  1989-08-25     Completed Date:  1989-08-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  41B-43B     Citation Subset:  AIM; IM    
Affiliation:
HGH-McMaster Clinic, Hamilton General Hospital, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Double-Blind Method
Drug Administration Schedule
Echocardiography
Heart Diseases / etiology,  prevention & control*
Heparin / administration & dosage*,  blood
Humans
Myocardial Infarction / complications,  drug therapy*
Partial Thromboplastin Time
Thrombosis / etiology,  prevention & control*
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antithrombotic therapy in the primary prevention of acute myocardial infarction.
Next Document:  Postnatal development of the Sertoli cell barrier, tubular lumen, and cytoskeleton of Sertoli and my...